Bhaduri G, Samajdar SS, Bandyopadhyay S, Mukherjee S, et al. Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD, and Stage 3 chronic kidney disease: A 12-month observational study. Diabetes Obes Metab 2025 Dec 10. doi: 10.1111/dom.70370.
PMID: 41369029